Search The Medical Knowledge Base

Search:

Medical News by Category

Flutiform delays in EU for treatment approval for Asthma

21 Oct 2011

Mundipharma/Napp filed Flutiform (fluticasone propionate plus formoterol fumarate) for asthma using the decentralised procedure in the EU with the UK as reference state and has now encountered delays in achieving consensus amongst the reference states. A launch in 2011 now looks unlikely although most reference states have found the drug approvable.Skye Pharma is the originator of the drug.